Main Session
Sep 28
QP 07 - Predicting, Protecting, Preserving, and Pushing Dose in Rectal Cancer

1038 - Distinct Efficacy between Very Early-Onset Locally Advanced Rectal Cancer (VEO-LARC) and Late-Onset LARC Receiving Total Neoadjuvant Therapy with or without Immunotherapy

08:15am - 08:20am ET

Presenter(s)

Luoxi He, - Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai,